English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
 
 
DownloadE-Mail
  Association of the EGF-TM7 receptor CD97 expression with FLT3-ITD in acute myeloid leukemia

Wobus, M., Bornhaeuser, M., Jacobi, A., Kraeter, M., Otto, O., Ortlepp, C., et al. (2015). Association of the EGF-TM7 receptor CD97 expression with FLT3-ITD in acute myeloid leukemia. ONCOTARGET, 6(36), 38804-38815. doi:10.18632/oncotarget.5661.

Item is

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Wobus, Manja1, Author
Bornhaeuser, Martin1, Author
Jacobi, Angela1, Author
Kraeter, Martin1, Author
Otto, Oliver1, Author
Ortlepp, Claudia1, Author
Guck, Jochen2, Author           
Ehninger, Gerhard1, Author
Thiede, Christian1, Author
Oelschlaegel, Uta1, Author
Affiliations:
1external, ou_persistent22              
2External Organizations, ou_persistent22              

Content

show
hide
Free keywords: bone marrow microenvironment;
 Abstract: Internal tandem duplications within the juxtamembrane region of the FMS-like tyrosine kinase receptor FLT3 (FLT3-ITD) represents one of the most common mutations in patients with acute myeloid leukemia (AML) which results in constitutive aberrant activation, increased proliferation of leukemic progenitors and is associated with an aggressive clinical phenotype. The expression of CD97, an EGF-TM7 receptor, has been linked to invasive behavior in thyroid and colorectal cancer. Here, we have investigated the association of CD97 with FLT3-ITD and its functional consequences in AML.
Higher CD97 expression levels have been detected in 208 out of 385 primary AML samples. This was accompanied by a significantly increased bone marrow blast count as well as by mutations in the FLT3 gene. FLT3-ITD expressing cell lines as MV4-11 and MOLM-13 revealed significantly higher CD97 levels than FLT3 wildtype EOL-1, OCI-AML3 and HL-60 cells which were clearly decreased by the tyrosine kinase inhibitors PKC412 and SU5614. CD97 knock down by short hairpin RNA in MV4-11 cells resulted in inhibited trans-well migration towards fetal calf serum (FCS) and lysophosphatidic acid (LPA) being at least in part Rho-A dependent. Moreover, knock down of CD97 led to an altered mechanical phenotype, reduced adhesion to a stromal layer and lower wildtype FLT3 expression.
Our results, thus, constitute the first evidence for the functional relevance of CD97 expression in FLT3-ITD AML cells rendering it a potential new theragnostic target.

Details

show
hide
Language(s): eng - English
 Dates: 2015
 Publication Status: Issued
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: -
 Identifiers: DOI: 10.18632/oncotarget.5661
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: ONCOTARGET
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA : IMPACT JOURNALS LLC
Pages: - Volume / Issue: 6 (36) Sequence Number: - Start / End Page: 38804 - 38815 Identifier: -